All In Biotech

Drug Trial Radar · NCT00308711

Safety/Efficacy Study Comparing the Misoprostol Vaginal Insert to Cervidil for Cervical Ripening and Induction of Labor

A Multi-center, Randomized, Double-blind Phase III Study of the Efficacy and Safety of the Misoprostol Vaginal Insert Compared to Cervidil for Women Requiring Cervical Ripening and Induction of Labor (The MVP Study).

Last checked: Nov 19, 2026Latest source record: Jun 25, 2012 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingPhase 3. Randomized with 1,308 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

1,308

Actual

Start

Apr 2006

Primary completion

Aug 2007

Study completion Aug 2007

Sponsor

Lead sponsor
Ferring PharmaceuticalsIndustry
Sponsor type
Industry
First posted
Mar 30, 2006

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
Who can join
Female only, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to determine whether the misoprostol vaginal insert (50 mcg and 100 mcg) can safely and effectively speed time to vaginal delivery compared to Cervidil (R) in women who need to have cervical ripneing and induction of labor.

Conditions

  • Cervical Ripening
  • Labor, Induced

Interventions

  • Misoprostol vaginal insert 100 mcgDrug

    Hydrogel polymer intravaginal insert with retrieval system. One insert is to remain in the posterior fornix of the vagina until removed for one of the following conditions: onset of active labor; maternal/fetal complication, e.g. non-reassuring fetal heart rate. Record if the insert falls out prior to meeting one of the first two criteria. In no case is the insert to remain in place longer than 24h.

  • Misoprostol vaginal insert 50 mcgDrug

    Hydrogel polymer intravaginal insert with retrieval system. One insert is to remain in the posterior fornix of the vagina until removed for one of the following conditions: onset of active labor; maternal/fetal complication, e.g. non-reassuring fetal heart rate. Record if the insert falls out prior to meeting one of the first two criteria. In no case is the insert to remain in place longer than 24h.

  • Dinoprostone vaginal insert (Cervidil)Drug

    Hydrogel polymer intravaginal insert with retrieval system. One insert is to remain in the posterior fornix of the vagina until removed for one of the following conditions: onset of active labor; maternal/fetal complication, e.g. non-reassuring fetal heart rate. Record if the insert falls out prior to meeting one of the first two criteria. In no case is the insert to remain in place longer than 24h.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Minutes From Drug Insertion to Vaginal DeliveryTime frame: 2880 minutes
  2. Percentage of Participants With a Cesarean Section DeliveryTime frame: 2880 minutes

Locations

52 sites in 2 countries. Site status is shown where the registry gives one.

  • University of Alabama at Birmingham Medical Center

    Birmingham, Alabama

  • Banner Desert Medical Center

    Mesa, Arizona

  • Maricopa Medical Center

    Phoenix, Arizona

  • Arizona Wellness Center for Women

    Phoenix, Arizona

  • Tuscon Medical Center

    Tucson, Arizona

  • Long Beach Memorial Medical Center

    Long Beach, California

  • UCI Medical Center

    Orange, California

  • Santa Clara Valley Medical Center

    San Jose, California

  • Christiana Care Health System

    Newark, Delaware

  • Bayfront Medical Center

    St. Petersburg, Florida

  • University of Florida Health Sciences Center

    Tampa, Florida

  • St. Mary's Medical Center

    West Palm Beach, Florida

  • Northside Hospital

    Alpharetta, Georgia

  • Hurley Medical Center

    Flint, Michigan

  • University of Minnesota Medical Center

    Minneapolis, Minnesota

  • St. Elizabeth Regional Medical Center

    Lincoln, Nebraska

  • Morristown Memorial Hospital

    Morristown, New Jersey

  • University of New Mexico Medical Center

    Albuquerque, New Mexico

  • United Health Services Hospitals, Inc.

    Johnson City, New York

  • Winthrop-South Nassau University Health Center

    Mineola, New York

  • NYU School of Medicine

    New York, New York

  • Columbia University Medical Center

    New York, New York

  • Jacobi Medical Center

    The Bronx, New York

  • Women's Health Alliance

    Winston-Salem, North Carolina

  • University of Cincinnati Holmes Hospital

    Cincinnati, Ohio

  • Ohio State University Medical Center

    Columbus, Ohio

  • Miami Valley Hospital

    Dayton, Ohio

  • University of Oklahoma Health Sciences Center

    Oklahoma City, Oklahoma

  • Legacy Center for Maternal-Fetal Medicine

    Portland, Oregon

  • Abington Memorial Hospital

    Abington, Pennsylvania

  • Lehigh Valley Medical Center

    Allentown, Pennsylvania

  • Temple University Hospital

    Philadelphia, Pennsylvania

  • University of Pittsburgh - Magee Women's Hospital

    Pittsburgh, Pennsylvania

  • Lankenau Hospital

    Wynnewood, Pennsylvania

  • Greenville Hospital System

    Greenville, South Carolina

  • Trident Health System

    North Charleston, South Carolina

  • Erlanger Hospital

    Chattanooga, Tennessee

  • University of Tennesse Medical Center

    Knoxville, Tennessee

  • Baptist Memorial Hospital

    Memphis, Tennessee

  • Methodist Charlton Medical Center

    Dallas, Texas

Showing 40 of 52 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.